Chronic Myelogenous Leukemia in Adults

We conduct sophisticated diagnostic tests such as chromosomal analysis to identify chronic myelogenous leukemia, a slow-growing cancer of the bone marrow and blood. We offer targeted chemotherapy that helps some people achieve long-term remission, in which cancer cells are no longer detected in the body. Stem cell transplantation is available for more aggressive cancer. We also provide psychosocial support to help you thrive during treatment for this chronic condition.

Clinical Trials and Research Studies

Phase 1

A Phase 1 Study Evaluating Safety Tolerability and Pharmacokinetics of Escalating Doses of AGS62P1 Given as Monotherapy in Subjects with Acute Myeloid Leukemia (AML)

Phase 2

AALL1521: INCB 18424-269 A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic Leukemia (ALL)

Phase 3

AALL1331; Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467 NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

Phase 3

Treatment Of Patients Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) Or Localized B-Lineage Lymphoblastic Lymphoma